8:00 am Coffee & Networking

8:25 am Chairs Opening Remarks

Sourcing, Extraction and Formulation of Cannabinoids

8:30 am Discussing the Challenges in Sourcing, Extracting and Formulating Cannabinoids

9:00 am Toward the Establishment of GMP Process: From Cannabis Extraction Methods to Nanotechnology-Based Formulations

Advancements in Technology to Increase the Therapeutic Potential of CDP

9:30 am Improving Cannabinoid Dosage Forms: Inhaled and Oral

10:00 am Morning Refreshments & Scientific Poster Session

11:00 am Drug Target Prediction and Development Using an Integrated Computational and High-Throughput Screening Approach

Discussing the Challenges in Pre-Clinical & Clinical Trials and Linking Cannabinoids to Their Therapeutic Potential

11:30 am Discovery and Development of a Cannabinoid-Derived Therapeutic for Glioblastoma

12:00 pm The Future of Inhaled Cannabinoid-Based Medicine in Cancer: An Alternative Treatment to Improve Quality of Life and Pain Management in Advanced Cancer Patients?

  • Aurelia De Pauw Vice-President Clinical Programs/ Medical Affairs , Tetra Bio-Pharma

12:30 pm Networking Lunch

1:30 pm A Party of Three: The Intriguing Interplay Between Three Cannabinoids for the Treatment of Insomnia

2:00 pm The Development of Cannabinoids for the Management of Ocular Diseases

2:30 pm Afternoon Refreshments

3:00 pm Linking Cannabinoids to Their Therapeutic Potential Opportunities and Challenges in Clinical Trials with Focus on Multiple Sclerosis

3:30 pm Challenges in Medical Cannabis Research and Translation to Clinical Practice

Understanding the Future of CDP and Its Role in Society

4:00 pm How to Progress Access to Medical Cannabis in the UK

4:30 pm Chair’s Closing Remarks & End of Conference